NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA

被引:46
作者
Wang, Feng [1 ]
Zhang, Peng [1 ]
Ma, Yanlei [1 ]
Yang, Jianjun [1 ]
Moyer, Mary Pat [2 ]
Shi, Chenzhang [1 ]
Peng, Jiayuan [1 ]
Qin, Huanlong [1 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Surg, Shanghai 200233, Peoples R China
[2] INCELL Corp, San Antonio, TX 78249 USA
关键词
NIRF; Let-7a; CRC; Overall survival; Oncogenicity; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; SRA DOMAIN; PROTEIN; BIOMARKERS; PATHWAYS; FAMILY; CELLS;
D O I
10.1016/j.canlet.2011.09.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Np95 ICBP90 RING finger (NIRF) is essential for the regulation of cell proliferation and has been implicated in tumorigenesis. However, the role of NIRF in colorectal cancer (CRC) remains unclear. In this study, we demonstrated that NIRF expression was aberrantly increased in CRC tissues and associated with poor overall survival. Bioinformatics analysis indicated that NIRF was a putative target of the microRNA let-7a, which was confirmed by luciferase reporter assay. We then demonstrated in vitro that enforced expression of let-7a, or knockdown of NIRF, led to reduced CRC cell proliferation due to cell cycle arrest at the G0/G1 phase and reduced cell migration. Finally, an in vivo tumorigenicity assay in nude mice showed that synthetic let-7a suppressed NIRF expression and reduced tumor growth. Taken together, our results provide new evidence that NIRF has an oncogenic role in CRC. This opens up the possibility of targeting NIRF and let-7a for CRC therapy. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 27 条
[1]   The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression [J].
Achour, M. ;
Jacq, X. ;
Ronde, P. ;
Alhosin, M. ;
Charlot, C. ;
Chataigneau, T. ;
Jeanblanc, M. ;
Macaluso, M. ;
Giordano, A. ;
Hughes, A. D. ;
Schini-Kerth, V. B. ;
Bronner, C. .
ONCOGENE, 2008, 27 (15) :2187-2197
[2]   TGF-β and cancer [J].
Bierie, B ;
Moses, HL .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) :29-40
[3]   The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future? [J].
Bronner, Christian ;
Achour, Mayada ;
Arima, Yoshimi ;
Chataigneau, Thierry ;
Saya, Hideyuki ;
Schini-Kerth, Valerie B. .
PHARMACOLOGY & THERAPEUTICS, 2007, 115 (03) :419-434
[4]   siRNAs can function as miRNAs [J].
Doench, JG ;
Petersen, CP ;
Sharp, PA .
GENES & DEVELOPMENT, 2003, 17 (04) :438-442
[5]   MicroRNA dysregulation in colorectal cancer: a clinical perspective [J].
Dong, Y. ;
Wu, W. K. K. ;
Wu, C. W. ;
Sung, J. J. Y. ;
Yu, J. ;
Ng, S. S. M. .
BRITISH JOURNAL OF CANCER, 2011, 104 (06) :893-898
[6]   Differential effects of phorbol ester on signaling and gene expression in human leukemia cells [J].
Hass, R ;
Prudovsky, I ;
Kruhoffer, M .
LEUKEMIA RESEARCH, 1997, 21 (07) :589-594
[7]   Let-7a elevates p21WAF1 levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells [J].
He, Xiaoyan ;
Duan, Changzhu ;
Chen, Junxia ;
Ou-Yang, Xi ;
Zhang, Zheng ;
Li, Chunlei ;
Peng, Huimin .
FEBS LETTERS, 2009, 583 (21) :3501-3507
[8]   MicroRNA control of signal transduction [J].
Inui, Masafumi ;
Martello, Graziano ;
Piccolo, Stefano .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (04) :252-263
[9]   Cancer statistics, 2008 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Murray, Taylor ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96
[10]   The let-7 MicroRNA represses cell proliferation pathways in human cells [J].
Johnson, Charles D. ;
Esquela-Kerscher, Aurora ;
Stefani, Giovanni ;
Byrom, Nlike ;
Kelnar, Kevin ;
Ovcharenko, Dmitriy ;
Wilson, Mike ;
Wang, Xiaowei ;
Shelton, Jeffrey ;
Shingara, Jaclyn ;
Chin, Lena ;
Brown, David ;
Slack, Frank J. .
CANCER RESEARCH, 2007, 67 (16) :7713-7722